Selective 5-HT3 receptor antagonist, has a significant inhibitory effect on nausea and vomiting caused by anticancer drugs such as cisplatin

Thyroid hormone drugs. This product is a synthetic sodium tetraiodothyronine, which is converted into triiodothyronine (T3) in the body and its activity is enhanced. It has the functions of maintaining normal growth and development of the human body, promoting metabolism, increasing heat production and improving the sensitivity of the sympathetic-adrenal system.

This product itself is inactive. After oral absorption, its hydrolysis product competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl coenzyme A reductase in the cholesterol synthesis process in the body, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors. The main site of action is in the liver, resulting in lower blood cholesterol and low-density lipoprotein cholesterol levels, moderately lower serum triglyceride levels and increased blood high-density lipoprotein levels. This has an effect on the prevention and treatment of atherosclerosis and coronary heart disease.

Non-steroidal anti-inflammatory drugs have significant anti-inflammatory, analgesic and antipyretic effects; they can inhibit prostate synthase, and more than 99% of them are bound to serum albumin at therapeutic doses, and 95% are excreted in the urine in the form of prototypes and metabolites.